Lv5
1378 积分 2024-07-02 加入
Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant immunochemotherapy in gastric cancer
4天前
已完结
Pan-cancer spatial atlas of tertiary lymphoid structures
4天前
已完结
LEF1 and niche factors determine T cell stemness across chronic diseases
5天前
已完结
Spatially Sussing Out the TME, No Tissue Needed
5天前
已关闭
Chemotherapy for patients with circulating tumour DNA-positive, stage II colon cancer (CIRCULATE)-an AIO/ABCSG trial
5天前
已完结
Efficacy of Perioperative Pembrolizumab in Mismatch Repair Deficient/Microsatellite Unstable Localized Colorectal Cancers: Results of the Phase II Trial IMHOTEP
6天前
已完结
Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
6天前
已完结
Does gut oxygenation drive colorectal cancer?
7天前
已完结
Tumor cells metabolically resist immune-checkpoint therapy by macrophage efferocytosis-mediated fatty acid recycling
10天前
已完结
Neoadjuvant toripalimab plus celecoxib versus toripalimab monotherapy for mismatch repair-deficient or microsatellite instability-high, locally advanced colorectal cancer (PICC-2): an open-label, multicentre, randomised, phase 2 trial
10天前
已完结
皖公网安备34019202002308
